Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Select Medical Holdings (SEM) over the last 14 years, with Q3 2025 value amounting to $784000.0.

  • Select Medical Holdings' Amortization of Deferred Charges fell 38.12% to $784000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 33.04%. This contributed to the annual value of $3.0 million for FY2024, which is 1193.8% up from last year.
  • As of Q3 2025, Select Medical Holdings' Amortization of Deferred Charges stood at $784000.0, which was down 38.12% from $786000.0 recorded in Q2 2025.
  • Select Medical Holdings' 5-year Amortization of Deferred Charges high stood at $787000.0 for Q3 2024, and its period low was $543000.0 during Q1 2021.
  • In the last 5 years, Select Medical Holdings' Amortization of Deferred Charges had a median value of $609000.0 in 2023 and averaged $655368.4.
  • Over the last 5 years, Select Medical Holdings' Amortization of Deferred Charges had its largest YoY gain of 3274.34% in 2024, and its largest YoY loss of 855.61% in 2024.
  • Over the past 5 years, Select Medical Holdings' Amortization of Deferred Charges (Quarter) stood at $562000.0 in 2021, then rose by 2.49% to $576000.0 in 2022, then rose by 29.86% to $748000.0 in 2023, then fell by 8.56% to $684000.0 in 2024, then rose by 14.62% to $784000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $784000.0 for Q3 2025, versus $786000.0 for Q2 2025 and $783000.0 for Q1 2025.